Page 88 | Certara

Publication

Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique

Characterising the small intestine absorptive membrane is essential to enable prediction of the systemic exposure…

CertaraAugust 29, 2023

Announcement

Certara Launches v11.0 of SEND Explorer

Delivers advanced data analysis and visualization capabilities to support nonclinical scientists PRINCETON, N.J.— August 28,…

CertaraAugust 28, 2023

Blog

Payers’ reaction to the IRA’s Medicare Part D Redesign

On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 (IRA) into…

CertaraAugust 25, 2023

Poster

AMCP Poster – A survey-based analysis of the determinants of management in traditionally unmanaged categories of oncology and rare diseases

CertaraAugust 25, 2023

Publication

Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion

Physiologically based pharmacokinetic (PBPK) models are useful in bridging drug exposure in different ethnic groups,…

CertaraAugust 21, 2023

Publication

Development and application of a PBPK modeling strategy to support antimalarial drug development

As part of a collaboration between Medicines for Malaria Venture (MMV), Certara UK and Monash…

CertaraAugust 18, 2023

Blog

Stop if you don’t have an unambiguous drug effect for your new molecular entity!

As a pharmacologist, I’ve always been curious about how drugs work. A favorite time-killer while…

CertaraAugust 18, 2023

Conference

CDISC China Interchange

CertaraAugust 17, 2023

Publication

Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases

Successful clinical development of new therapeutic interventions is notoriously difficult, especially in neurodegenerative diseases, where…

CertaraAugust 15, 2023

On-Demand Webinar

IRA impacts: First 10 drugs selected for the Drug Price Negotiation Program

The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…

CertaraAugust 15, 2023

Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique

Certara Launches v11.0 of SEND Explorer

Payers’ reaction to the IRA’s Medicare Part D Redesign

AMCP Poster – A survey-based analysis of the determinants of management in traditionally unmanaged categories of oncology and rare diseases

Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion

Development and application of a PBPK modeling strategy to support antimalarial drug development

Stop if you don’t have an unambiguous drug effect for your new molecular entity!

CDISC China Interchange

Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases

IRA impacts: First 10 drugs selected for the Drug Price Negotiation Program

Newsletter sign up

Quick links

Solutions

Contact